Texas Institute for Genomic Medicine
From Wikipedia, the free encyclopedia
The Texas Institute for Genomic Medicine (TIGM) is a 501(c)(3) non-profit institute founded in 2005 under a $50 million award from the Texas Enterprise Fund to pioneer the development of life-changing medical breakthroughs, accelerate the pace of medical discoveries and foster the development of the biotechnology industry in Texas[1]. TIGM is developing the world's largest C57-based gene trap library that will contain more than 300,000 sequence tagged clones covering more than 17,000 unique genes.
